The role of liposomes in clinical nanomedicine development. What now? Now what?

J Control Release. 2020 Feb:318:256-263. doi: 10.1016/j.jconrel.2019.12.023. Epub 2019 Dec 14.

Abstract

The rapid rise in interest in 'nanomedicines' in the academic world over the last twenty years and the claims of success led to calls for reflection. The main body of text of this Commentary will be on answering the question: 'where to go with nanomedicines'? Research priorities for the future will be outlined based on experience with the most successful nanomedicines family within the broad field of nanomedicine so far: liposomes. An analysis of currently clinically tested, approved and marketed liposome-drug combinations provides these insights.

Keywords: Clinical trials; Liposomes; Nanomedicines.

Publication types

  • Review

MeSH terms

  • Drug Delivery Systems
  • Liposomes*
  • Nanomedicine*

Substances

  • Liposomes